Ownership history in Stratos Wealth Partners, LTD. · 6 quarters on record
This page tracks every 13F SEC filing in which Stratos Wealth Partners, LTD. reported a position in PROTALIX BIOTHERAPEUTICS INC (PLX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 500,000 | — | 0% | 0.01% | $900K | $1.80 |
| 2025 Q3 | ADDED | 500,000 | +150,000 | +42.9% | 0.01% | $1.1M | $2.22 |
| 2025 Q2 | ADDED | 350,000 | +3,600 | +1.0% | 0.01% | $518K | $1.48 |
| 2025 Q1 | ADDED | 346,400 | +76,400 | +28.3% | 0.01% | $887K | $2.56 |
| 2024 Q4 | UNCHANGED | 270,000 | — | 0% | 0.01% | $508K | $1.88 |
| 2024 Q3 | INITIATED | 270,000 | — | — | 0.00% | $275K | $1.02 |
As of 2025 Q4 — sorted by position size